InvestorsHub Logo
icon url

exwannabe

03/16/11 11:58 AM

#116523 RE: biomaven0 #116522

What do you make of the fact that the FDA argument here rests solely on the lack of a good and stable raw material supplier - not one word in there about lack of "sameness" or failure to meet their 5 criteria?



How can they comment on Amphastar meeting the sameness criterion when they have yet to receive evaluable material?

icon url

jq1234

03/16/11 12:03 PM

#116524 RE: biomaven0 #116522

What do you make of the fact that the FDA argument here rests solely on the lack of a good and stable raw material supplier - not one word in there about lack of "sameness" or failure to meet their 5 criteria?



Here are the answers on page 14:

D. Amphastar relied upon a defunct heparin supplier in generating its data
regarding active ingredient “sameness” and impurities.


Because heparin from different manufacturers is not necessarily equivalent, and can differ
in key quality attributes, AR 464, FDA concluded that the data that Amphastar had submitted to
demonstrate “sameness” as to enoxaparin made from heparin supplied by KY, could not be
presumed to support a conclusion of “sameness” as to enoxaparin made from heparin supplied by
QJBC. AR 464-65. Differences in the quality of crude heparin used to produce heparin, or in
manufacturing and purification processes, could be material. AR 464. For the same reasons, FDA concluded that the data that Amphastar had submitted regarding impurities were
incomplete, because heparin from different suppliers could have different impurity profiles. AR
464-65.

In December 2008, FDA informed Amphastar that the ANDA was not approvable for
lack of complete data regarding active ingredient sameness and impurities.



Thus, there is no point to argue whether they actually achieved "sameness" when the data generated considered invalid.
icon url

10nisman

03/16/11 12:11 PM

#116525 RE: biomaven0 #116522

D. Amphastar relied upon a defunct heparin supplier in generating its data regarding active ingredient “sameness” and impurities.

One would think if Amphastar could determine "sameness" they would have determined they were working with bad heparin.
icon url

DewDiligence

03/16/11 12:32 PM

#116527 RE: biomaven0 #116522

You have to get to first base before you can get to second base, third base, or home plate. Amphastar is not even at first base yet.